Sirolimus may promote thrombotic microangiopathy Academic Article Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Carcinoma, Squamous Cell
  • Carcinoma, Transitional Cell
  • Neoplasms, Multiple Primary
  • Urologic Neoplasms

abstract

  • In this patient with a renal allograft, conversion from tacrolimus to sirolimus was associated with the appearance of severe thrombotic microangiopathy. Sirolimus discontinuation resulted was followed by full recovery, suggesting that the sirolimus played a role in the thrombotic microangiopathy.

publication date

  • February 2003

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1034/j.1600-6143.2003.00018.x

PubMed ID

  • 12603218

Additional Document Info

start page

  • 229

end page

  • 30

volume

  • 3

number

  • 2